News

GlobalData on MSN23h

Assembly Bio’s herpes drug shows 94% drop in viral shedding

Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...

Dr. Roy Levitt, Executive Chairman of Adolore BioTherapeutics, Presented at the Next Generation Gene Therapy Vectors Summit

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that ...

Adolore Biotherapeutics, Inc.: Dr. Roy Levitt, Executive Chairman of Adolore BioTherapeutics, Presented at the Next Generation Gene Therapy Vectors Summit

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Pr ...
Newsworthy Women on MSN17h

She Built a $4.4B Biotech From One Bold Idea at Age 51

In 2016, veteran drug developer Suma Krishnan was in her early 50s when she began to seriously consider a radically different ...
The Scientist5h

Herpes Hijacks a Host Enzyme. Blocking It Could Prevent Cold Sores.

The cold sore virus takes over its host’s transcription machinery to replicate itself. Inhibiting a host enzyme can halt ...